seed
Stage
2025
Founded
1
Investors
About
Renasant Bio develops oral small molecule therapies that restore the function of polycystin proteins to treat autosomal dominant polycystic kidney disease (ADPKD) by targeting the root biological causes of the disease.
Explore Renasant Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.